Povetacicept reduces disease activity in MG mouse model
Povetacicept reduced disease activity in a mouse model of MG by reducing the levels of disease-causing antibodies in the bloodstream.| Myasthenia Gravis News
Povetacicept reduced disease activity in a mouse model of MG by reducing the levels of disease-causing antibodies in the bloodstream.| Myasthenia Gravis News
Myasthenia gravis is a neuromuscular disease characterized by weakness and fatigue that can affect muscles involved in voluntary movements.| Myasthenia Gravis News
